• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用美国全国代表性样本开发简短心理健康障碍量表。

Development of a brief mental health impairment scale using a nationally representative sample in the USA.

机构信息

RT International, Research Triangle Park, NC, USA.

出版信息

Int J Methods Psychiatr Res. 2010 Jun;19 Suppl 1(Suppl 1):49-60. doi: 10.1002/mpr.313.

DOI:10.1002/mpr.313
PMID:20527005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7003704/
Abstract

A psychometric analysis was conducted to reduce the number of items needed to assess the disability associated with mental disorders using the World Health Organization Disability Assessment Schedule (WHODAS). The WHODAS was to be used in the Substance Abuse and Mental Health Services Administration National Survey on Drug Use and Health (NSDUH), beginning in 2008, as part of a screening algorithm to produce estimates of the prevalence of serious mental illness (SMI) in the US adult population. The goal of the work presented in this paper was to create a parsimonious screening scale from the full 16-item WHODAS that was administered to 24,156 respondents (aged 18+) in the 2002 NSDUH. Exploratory factor analysis showed that WHODAS responses were unidimensional. A two-parameter polytomous Item Response Theory model showed that all 16 WHODAS items had good item discrimination (slopes greater than 1.0) for each response option. Analysis of item difficulties and differential item function across socio-demographic categories was then used to select a subset of eight items to create a short version of the WHODAS. The Pearson correlation between scores in the original 16-item and reduced eight-item WHODAS scales was 0.97, documenting that the vast majority of variation in total scale scores was retained in the reduced scale.

摘要

采用世界卫生组织残疾评定量表(WHODAS)对与精神障碍相关的残疾进行评估,需要对项目进行删减以减少所需项目的数量。自 2008 年起,该量表将被用于药物滥用和心理健康服务管理局国家药物使用和健康调查(NSDUH),作为产生美国成年人群体严重精神疾病(SMI)流行率估计值的筛选算法的一部分。本文介绍的工作旨在从对 24156 名(年龄在 18 岁及以上)受访者进行的 2002 年 NSDUH 中使用的完整的 16 项 WHODAS 中创建一个简约的筛选量表。探索性因素分析表明,WHODAS 的反应是单维的。双参数多项逻辑斯蒂克项目反应理论模型表明,WHODAS 的所有 16 个项目对于每个反应选项都具有良好的项目区分度(斜率大于 1.0)。然后,对社会人口统计学类别中的项目难度和差异项目功能进行分析,以选择 8 个项目子集来创建 WHODAS 的简短版本。原始的 16 项和简化的 8 项 WHODAS 量表的得分之间的 Pearson 相关系数为 0.97,证明在简化量表中保留了总量表得分的绝大多数变化。

相似文献

1
Development of a brief mental health impairment scale using a nationally representative sample in the USA.使用美国全国代表性样本开发简短心理健康障碍量表。
Int J Methods Psychiatr Res. 2010 Jun;19 Suppl 1(Suppl 1):49-60. doi: 10.1002/mpr.313.
2
The National Survey on Drug Use and Health Mental Health Surveillance Study: calibration analysis.全国药物使用与健康调查——精神健康监测研究:校准分析。
Int J Methods Psychiatr Res. 2010 Jun;19 Suppl 1(Suppl 1):61-87. doi: 10.1002/mpr.312.
3
The National Survey on Drug Use and Health Mental Health Surveillance Study: calibration study design and field procedures.全国药物使用与健康调查精神卫生监测研究:校准研究设计和现场程序。
Int J Methods Psychiatr Res. 2010 Jun;19 Suppl 1(Suppl 1):36-48. doi: 10.1002/mpr.311.
4
Characterization of Disability in Canadians with Mental Disorders Using an Abbreviated Version of a DSM-5 Emerging Measure: The 12-Item WHO Disability Assessment Schedule (WHODAS) 2.0.使用《精神疾病诊断与统计手册》第5版(DSM-5)一项新出现的简版量表对加拿大精神障碍患者的残疾情况进行特征描述:12项世界卫生组织残疾评定量表(WHODAS)2.0。
Can J Psychiatry. 2016 Apr;61(4):227-35. doi: 10.1177/0706743716632514. Epub 2016 Feb 16.
5
Confirmatory factor analysis of the 12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS-2.0) within the clubhouse model of psychosocial rehabilitation for serious mental illness.12 项世界卫生组织残疾评定量表 2.0(WHODAS-2.0)在心理社会康复会所模式下用于严重精神疾病的验证性因子分析。
Psychiatr Rehabil J. 2024 Sep;47(3):229-239. doi: 10.1037/prj0000594. Epub 2023 Dec 14.
6
[Validity and Reliability of the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) in Turkish Psychiatry Patients and Healthy Controls].[世界卫生组织残疾评定量表2.0(WHODAS 2.0)在土耳其精神病患者和健康对照人群中的效度与信度]
Turk Psikiyatri Derg. 2018 Winter;29(4):248-257.
7
Measurement invariance of the 12-item self-administered World Health Organization Disability Assessment Schedule (WHODAS) 2.0 across early and late adolescents in Canada.12项自评式世界卫生组织残疾评定量表(WHODAS)2.0在加拿大青少年早期和晚期的测量不变性。
Disabil Rehabil. 2023 Sep;45(19):3118-3124. doi: 10.1080/09638288.2022.2118867. Epub 2022 Sep 9.
8
Validation of the World Health Organization Disability Assessment Schedule in people with severe mental disorders in rural Ethiopia.世界卫生组织残疾评定量表在埃塞俄比亚农村重症精神障碍患者中的效度验证
Health Qual Life Outcomes. 2017 Apr 5;15(1):64. doi: 10.1186/s12955-017-0647-3.
9
Screening for serious mental illness in the general population with the K6 screening scale: results from the WHO World Mental Health (WMH) survey initiative.使用 K6 筛查量表在普通人群中筛查严重精神疾病:来自世界卫生组织世界心理健康调查倡议的结果。
Int J Methods Psychiatr Res. 2010 Jun;19 Suppl 1(Suppl 1):4-22. doi: 10.1002/mpr.310.
10
Why sample selection matters in exploratory factor analysis: implications for the 12-item World Health Organization Disability Assessment Schedule 2.0.为什么样本选择在探索性因素分析中很重要:对世界卫生组织残疾评估量表2.0(12项)的启示
BMC Med Res Methodol. 2017 Mar 11;17(1):40. doi: 10.1186/s12874-017-0309-5.

引用本文的文献

1
Cigarette Smoking Cessation Counselling in Pregnant Smokers with Mental Illness/Substance Use Disorders.孕期患有精神疾病/物质使用障碍的吸烟者的戒烟咨询。
West J Nurs Res. 2023 Mar;45(3):234-241. doi: 10.1177/01939459221127803. Epub 2022 Oct 4.
2
Racial and Ethnic Disparities in Health Status and Community Functioning Among Persons with Untreated Mental Illness.未治疗精神疾病者的健康状况和社区功能的种族和民族差异。
J Racial Ethn Health Disparities. 2023 Oct;10(5):2175-2184. doi: 10.1007/s40615-022-01397-1. Epub 2022 Sep 6.
3
Associations of Healthcare Service Utilization With Cannabis Use Status, Use Reasons, and Use Characteristics Among Those Age 50 and Older.50 岁及以上人群的医疗保健服务利用与大麻使用状况、使用原因和使用特征的关联。
J Appl Gerontol. 2022 May;41(5):1385-1396. doi: 10.1177/07334648211069997. Epub 2022 Feb 25.
4
Motivations for Prescription Drug Misuse Related to Mental Health Problems in Adults.成年人与心理健康问题相关的处方药物滥用动机。
Subst Use Misuse. 2022;57(2):316-327. doi: 10.1080/10826084.2021.2012687. Epub 2021 Dec 14.
5
Opioid use in pregnant women with mental health-related disabilities.患有精神健康相关残疾的孕妇使用阿片类药物的情况。
Arch Gynecol Obstet. 2021 Jun;303(6):1531-1537. doi: 10.1007/s00404-020-05953-0. Epub 2021 Jan 10.
6
Mental illness and the risk of self- and other-directed aggression: Results from the National Survey on Drug Use and Health.精神疾病与自我和他人指向性攻击的风险:来自国家药物使用与健康调查的结果。
J Psychiatr Res. 2021 Jan;132:161-166. doi: 10.1016/j.jpsychires.2020.10.010. Epub 2020 Oct 16.
7
Distress, Impairment, and Racial/Ethnic Differences in Perceived Need for Mental Health Treatment in a Nationally Representative Sample.在全国代表性样本中,痛苦、功能损害与心理健康治疗需求的种族/民族差异。
Psychiatry. 2020 Summer;83(2):149-160. doi: 10.1080/00332747.2020.1762394.
8
The Grand Challenge of Reducing Gender and Racial/Ethnic Disparities in Service Access and Needs Among Adults with Alcohol Misuse.减少酒精滥用成年人在服务获取和需求方面的性别及种族/族裔差异这一重大挑战。
J Soc Work Pract Addict. 2017;17(1-2):10-35. doi: 10.1080/1533256X.2017.1302887. Epub 2017 Apr 12.
9
Deriving alternative criteria sets for alcohol use disorders using statistical optimization: Results from the National Survey on Drug Use and Health.利用统计优化推导酒精使用障碍的替代标准集:来自全国药物使用和健康调查的结果。
Exp Clin Psychopharmacol. 2019 Jun;27(3):283-296. doi: 10.1037/pha0000249. Epub 2018 Dec 17.
10
Prescription opioid and benzodiazepine misuse is associated with suicidal ideation in older adults.阿片类处方药物和苯二氮䓬类药物的滥用与老年人的自杀意念有关。
Int J Geriatr Psychiatry. 2019 Jan;34(1):122-129. doi: 10.1002/gps.4999. Epub 2018 Oct 16.

本文引用的文献

1
The National Survey on Drug Use and Health Mental Health Surveillance Study: calibration analysis.全国药物使用与健康调查——精神健康监测研究:校准分析。
Int J Methods Psychiatr Res. 2010 Jun;19 Suppl 1(Suppl 1):61-87. doi: 10.1002/mpr.312.
2
The National Survey on Drug Use and Health Mental Health Surveillance Study: calibration study design and field procedures.全国药物使用与健康调查精神卫生监测研究:校准研究设计和现场程序。
Int J Methods Psychiatr Res. 2010 Jun;19 Suppl 1(Suppl 1):36-48. doi: 10.1002/mpr.311.
3
Screening for serious mental illness in the National Survey on Drug Use and Health (NSDUH).《全国药物使用和健康调查》(NSDUH)中严重精神疾病的筛查
Ann Epidemiol. 2009 Mar;19(3):210-1. doi: 10.1016/j.annepidem.2008.09.005.
4
The National Comorbidity Survey Replication (NCS-R): background and aims.全国共病调查复制研究(NCS-R):背景与目标。
Int J Methods Psychiatr Res. 2004;13(2):60-8. doi: 10.1002/mpr.166.
5
Mild disorders should not be eliminated from the DSM-V.轻度精神障碍不应从《精神疾病诊断与统计手册》第五版中删除。
Arch Gen Psychiatry. 2003 Nov;60(11):1117-22. doi: 10.1001/archpsyc.60.11.1117.
6
The performance of the K6 and K10 screening scales for psychological distress in the Australian National Survey of Mental Health and Well-Being.在澳大利亚全国心理健康与幸福调查中,K6和K10心理困扰筛查量表的表现。
Psychol Med. 2003 Feb;33(2):357-62. doi: 10.1017/s0033291702006700.
7
Screening for serious mental illness in the general population.普通人群中严重精神疾病的筛查。
Arch Gen Psychiatry. 2003 Feb;60(2):184-9. doi: 10.1001/archpsyc.60.2.184.
8
Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates.美国精神障碍患病率的修订估计:使用临床意义标准协调两项调查的估计值。
Arch Gen Psychiatry. 2002 Feb;59(2):115-23. doi: 10.1001/archpsyc.59.2.115.
9
Limitations of diagnostic criteria and assessment instruments for mental disorders. Implications for research and policy.精神障碍诊断标准和评估工具的局限性。对研究和政策的影响。
Arch Gen Psychiatry. 1998 Feb;55(2):109-15. doi: 10.1001/archpsyc.55.2.109.
10
Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.美国精神疾病诊断与统计手册第三版修订版(DSM-III-R)精神障碍的终生患病率和12个月患病率。来自国家共病调查的结果。
Arch Gen Psychiatry. 1994 Jan;51(1):8-19. doi: 10.1001/archpsyc.1994.03950010008002.